We are coming after you in Atlanta !

Addiction Sales Specialist - Atlanta, GA 6803-1412598

Description

Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. We helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market.

Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com

As the only global provider of commercial solutions, Quintiles understands what it takes to deliver nationally and internationally. Our teams help biopharma get their medicines to the people who need them. We help customers gain insight and access to their markets and ultimately demonstrate their product’s value to payers, physicians and patients. A significant part of our business is acting as the biopharma’s sales force to physicians or providing nurses to educate patients or prescribers. With the right experience, you can help deliver medical breakthroughs in the real world.

We are excited to announce that at this time we are looking for Addiction Sales Specialist to join our team of over 10,000 global field representatives in several regions making over 20 million product details annually for our pharmaceutical and biotech clients. In this role you will be supporting BioDelivery Sciences ("BDSI"®) a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine.

Addiction Sales Specialist
The Addiction Specialist (ADS) will be a customer facing role and will be expected to help develop and support a culture of high performance, accountability and integrity. The ADS will call on assigned territory healthcare providers, informing those healthcare providers about the features and benefits of our customer’s product BUNAVAIL™ (buprenorphine and naloxone) buccal film. The ADS will educate, develop and maintain strong relationships with assigned territory healthcare providers and their staff, to further the progress our customers business. The ADS will be expected to continuously improve selling skills, product and competitor product knowledge, by completing required training courses, working with your managers, and reviewing available information provided by management. The Addiction Specialist will work closely with their Regional Sales Manager and National Sales Director, to drive sales and to support in the planning and development of regional and national strategies.

CORE RESPONSIBILITIES:

Call on assigned territory healthcare providers, informing those healthcare providers about the features and benefits of Bunavail
Complete all administrative responsibilities in compliance with company policy including but not limited to; expense management, compliance and product training and call reporting.
Maintain a territory business plan
Complete all assigned corporate training
Adheres to company policies
Foster and support teamwork relationships throughout other areas of the company.
Support a culture of high performance, accountability and integrity
Ability to be agile in a fast moving, dynamic start-up company while focusing on territory growth and contributing to the bottom line


Quintiles offers a friendly, progressive work atmosphere and a comprehensive benefits package including medical, dental, life insurance and vision coverage, tuition assistance, bonus plan and 401(k).

We look forward to the prospect of working with you! Please apply on-line at: www.quintiles.com

EEOMinorities/Females/Protected Veterans/Disabled

Qualifications

Qualifications/Experience

Education required

Bachelor’s degree from a four-year college or university required.

Experience:

Minimum of 2 years pharmaceutical specialty sales experience in territories with individual accountability
Experience in Addiction Medicine, Psychiatry or Pain Management is a plus. Consistently a top 25% performer in prior positions/sales roles
Residence within geography is required

Preferred Skills/Qualifications:

Strong computer expertise including proficiency in Microsoft Word, Excel and PowerPoint.


Competencies

Drive for Results
Customer Focus
Work Ethic / Perseverance
Integrity and Trust
Problem Solving Critical thinking
Motivational Fit
Listening Persuasive Communication Skills

Primary Location
: USA-Georgia-Atlanta
Organization
: USA03 - US Commercialization

 

Heard BDSI will have over 100 Reps selling Bunuvail. Good luck with that.

 

Oh my God! Another copycat product...whatever will we do? Bunavail will be tied up in lawsuits for the next 5 years. Even if they get past that, good luck. They only got approval bc the judge threw out the case bc we cannot sue a product that hasn't been approved Their product that promises "same efficacy with lower dosing". Look at Zubsolv and see how well they're doing. Don't fucking tug on Superman's cape.

 

We are sooooo scared of you in Atlanta. Give us all you got !

 

Sure will...just like General Sherman burned Atlanta to the ground.

 

The offensive in Atlanta has begun! Beg for mercy now and maybe we will make your defeat less painful.

 

Bunavail is now available and Drs are now writing for it! Why do we have to learn these things from our physician's office? Good luck.

 

Thats funny, heard from BDSI rep, drug isnt available for a few more weeks

 

People come on here and try to pump stock price for BDSI. Give us a break. Their drug approval is still waiting for final approval as there was a hitch in one of their submissions. Should launch between thanksgiving and Christmas. Best time to launch.

 

Hey Genius! Try reading a newspaper once in a while....

RALEIGH, N.C., June 9, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) BDSI, -2.33% received approval of the New Drug Application (NDA) for BUNAVAIL™ (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA). BUNAVAIL is indicated for the maintenance treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support. BDSI expects to launch BUNAVAIL late in the third quarter of 2014.

 

all attempts to pump up stock price and pry out free competitive information. So much baiting and so much inflation of the truth. I love it. Shit in, shit out. Blurr everything.

 

So glad to see you RB losers had a 15% decrease in your business! More decreases to come!

 

That has nothing to do with you it is more generics and more access for Zubsolv within managed care. You will be lucky to get 1% when you launch B unavail next year.

 

Exactly. A majority of the loss was due to generics. Zubsolv has about 3% of the market, after a year. If you get even 5% I would call that a win, if your product is ever available.

 

We've been told Bunavail has a goal of 7% by end of year 1. Sounds aggressive but attainable. 5% is probably more realistic but we will see.

 

if you had a managed care team that knew what they were doing & you didn't have that moron RP who pissed off every account with company that hangs onto his dead wood ass you might have a shot

 

Good point!

 

I heard that BDSI hired their Reps back in June and many of them left Quintiles in the last month. They are trying to fill vacancies by end of year. Know someone whose company just hired one of the BDSI reps who told him the BDSI mgmt was clueless and misled them. We do not have to worry about them keep selling and good luck.

 

Really? Seriously? You still read a newspaper? What are you like 90? The majority of people use their phone/ipad these days for "news". Drill out the earwax, check the bingo stamper and stick on those dentures grandpa and get with the times.

 

pp small message board bully?